Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.16M Buy
1,382,906
+762,550
+123% +$4.77M 0.02% 787
2025
Q4
$4.53M Buy
620,356
+200,584
+48% +$1.94M 0.01% 826
2025
Q3
$4.18M Buy
+419,772
New +$4.65M 0.02% 758
2025
Q2
Sell
-416,549
Closed -$2.67M 2866
2025
Q1
$2.67M Buy
+416,549
New +$3.71M 0.02% 687
2024
Q4
Sell
-13,487
Closed -$110K 2612
2024
Q3
$110K Buy
+13,487
New +$140K ﹤0.01% 2041
2022
Q4
Sell
-75,330
Closed -$1.21M 2635
2022
Q3
$1.21M Buy
+75,330
New +$1.11M 0.01% 810
2022
Q2
Sell
-131,026
Closed -$1.64M 3119
2022
Q1
$1.64M Buy
+131,026
New +$1.84M 0.01% 727
2021
Q3
Sell
-23,323
Closed -$468K 3408
2021
Q2
$468K Sell
23,323
-703
-3% -$9.54K ﹤0.01% 1844
2021
Q1
$279K Buy
+24,026
New +$316K ﹤0.01% 2144

Other funds holding ENVX

HRT Financial's ENVX Position: Q1 2026 in Review

HRT Financial increased its Enovix (ENVX) stake by 123% in Q1 2026, buying an estimated $4.77M and bringing the position to 1,382,906 shares worth $7.16M. The position accounts for 0.02% of the portfolio, ranked #787.

HRT Financial first reported a position in ENVX in Q1 2021 and has held it in 9 quarters since. 306 funds tracked by Wall St. Rank hold ENVX as of Q1 2026.

  • HRT Financial held 1,382,906 shares of Enovix worth $7.16M as of Q1 2026.
  • HRT Financial bought 762,550 Enovix shares in Q1 2026, an estimated $4.77M.
  • Enovix made up 0.02% of HRT Financial's portfolio in Q1 2026, its #787 holding.
  • HRT Financial first reported a position in Enovix in Q1 2021 and has held it in 9 quarters since.
  • 306 funds tracked by Wall St. Rank held Enovix as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.